Clinical and biochemical effects of EHDP in Paget's disease of bone: Patterns of response to initial treatment and to long-term therapy
Authors:
- E.S. SirisESE.S. Siris
- R.E. CanfieldRCR.E. Canfield
- T.P. JacobsTJT.P. Jacobs
- K.E. StoddartKSK.E. Stoddart
- P.J. SpectorPSP.J. Spector
- 1 January 1981
- journal article
- clinical trial
- Published by Elsevier in Metabolic Bone Disease and Related Research
- Vol. 3 (4-5) , 301-308
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Response of 1α,25-Dihydroxyvitamin D3to Hypocalcemia in Human SubjectsNew England Journal of Medicine, 1978
- Diphosphonate Therapy of Paget's Disease of BoneThe Journal of Clinical Endocrinology & Metabolism, 1977
- Paget's disease of bone—a clinical and genetic study1977
- PAGET'S BONE DISEASE TREATED WITH DIPHOSPHONATE AND CALCITONINThe Lancet, 1976
- Coma due to hypercalcemia in a patient with Paget??s disease and multiple parathyroid adenomataThe American Journal of the Medical Sciences, 1975
- Response of Paget's disease to porcine and salmon calcitoninsThe American Journal of Medicine, 1974
- Effectiveness of parathyroid hormone, calcitonin and phosphate on bone cells in Paget's diseaseThe American Journal of Medicine, 1974
- Influence of Disodium Etidronate on Clinical and Laboratory Manifestations of Paget's Disease of Bone (Osteitis Deformans)New England Journal of Medicine, 1973
- PARATHYROID FUNCTION IN PATIENTS WITH PAGET'S DISEASE TREATED WITH SALMON CALCITONINClinical Endocrinology, 1973
- Hypoparathyroidism and Paget's Disease: The Effect of Parathyroid Hormone AdministrationThe Journal of Clinical Endocrinology & Metabolism, 1972